Why the study?
Does verapamil improve efficacy and safety outcomes compared to other antianginal agents in patients with chronic stable angina?
Does verapamil improve efficacy and safety outcomes compared to other antianginal agents in patients with chronic stable angina?
Verapamil is an effective and safe addition to existing drug regimens for the treatment of stable angina pectoris, provided patients are carefully selected to avoid contraindications like left ventricular dysfunction or conduction disease.
No takes yet. Share an insight, caveat, or question.
Supports verapamil consideration in selected stable angina patients; leaves open need for updated head-to-head trials.
William H. Frishman (1983) studied this question.